Answers are grounded in this paper and cite their sources.
Lycium ruthenicum anthocyanins exert neuroprotective activity in experimental models, but the relationships between intestinal anthocyanin exposure, gut microbial features, and transcriptional responses remain uncertain. Male 5 × FAD mice were divided into a vehicle control (ctl) group and an L. ruthenicum anthocyanin extract (Lr) group. Targeted UPLC-MS/MS, shotgun metagenomics, and RNA-seq were used to characterize fecal anthocyanin metabolites, the gut microbiome, and hippocampal gene expression, respectively. Forty-five fecal anthocyanin-related metabolites were detected, and nine met the exploratory fold-change screening criterion; only one also met the nominal p < 0.05 threshold. Alpha-diversity indices were numerically higher in the Lr group, whereas the overall microbial community structure did not differ between groups (p = 0.60). Descriptive taxonomic shifts and LEfSe candidates included lower Escherichia and higher relative abundances of Enterococcus, Akkermansia, Blautia caecimuris, and Roseburia hominis. In total, 196 genes met the exploratory differential-expression criteria. Bace2 was upregulated, whereas major histocompatibility complex class II (MHC-II) and chemokine-related genes were downregulated. In paired analyses across six animals, the Lactobacillus-related taxonomic score and the functional score based on carbohydrate-active enzymes (CAZy) database annotations each correlated with the hippocampal MHC-II module, but neither association remained significant after Benjamini–Hochberg correction. These findings identify coordinated fecal metabolic, microbial, and hippocampal transcriptional changes after Lr exposure, but they do not establish microbiota-mediated or disease-modifying effects.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: